2023 Approvals

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023

What is BRENZAVVY prescribed for?   BRENZAVVY is prescribed to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise. What is the name of the drug and what does it do? BRENZAVVY, pronounced bren-ZA-vee, (generic name: bexagliflozin) , is used to improve blood sugar control in adults with type 2 diabetes. It...

FDA Approves LetsGetChecked Simple 2 Test for Chlamydia and Gonorrhea: November 15, 2023

FDA Approves LetsGetChecked Simple 2 Test for Chlamydia and Gonorrhea: November 15, 2023

What is LetsGetChecked Simple 2 Test prescribed for?   The Simple 2 Home Sample Collection Kit is for anyone who is over the age of 18 who is sexually active and wants to test for chlamydia and gonorrhea. What is the name of the drug and what does it do?  The LetsGetChecked Simple 2 Test is an over-the-counter test that detects chlamydia and gonorrhea...

Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023

Zepbound Injection Approved for Weight Loss in Overweight and Obese Adults on November 8, 2023

What is Zepbound prescribed for?   Zepbound is prescribed for Chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in...

Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis

Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis

What is Zilbrysq prescribed for?   Zilbrysq is prescribed to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive. What is the name of the drug and what does it do?  Zilbrysq, pronounced ZIL-brisk, (generic name: zilucoplan) is  for generalized myasthenia gravis (MG) treatment in adults. ...

Brixadi Approved  for Treatment of Opioid Use Disorder on May 05, 2023

Brixadi Approved  for Treatment of Opioid Use Disorder on May 05, 2023

What is Brixadi prescribed for? Brixadi is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.  What is the name of the drug and what does it do? Brixadi, pronounced brix-a-dee, (generic name:...